Regulator’s BioLogics probe ends up inconclusive

Home > Business > Industry

print dictionary print

Regulator’s BioLogics probe ends up inconclusive

Korea’s financial regulator wrapped up its review of a regulatory probe into whether Samsung BioLogics violated accounting rules, officials said Friday.

Details of the review were not disclosed due to a confidentiality agreement, but the review apparently failed to reach a consensus because there were some “majority and minority opinions” about the case, the Financial Services Commission said.

The review came after financial authorities gave a preliminary notice earlier last month to Samsung BioLogics that it broke accounting rules in 2015, a charge that the company has strongly denied.

The outcome of the review will be delivered to the Securities and Futures Commission, which will hold a meeting on Thursday to try to reach a final ruling.


Yonhap

More in Industry

Kia plant hit with infections for second time this month

LG Chem gets a boost in battery patent lawsuit against SK Innovation

[TEST DRIVE] There are few rides more comfortable than the Volvo S90

India is the battleground country for Samsung and Apple

Hyundai Motor unveils two electric models at Beijing car show

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now